Washington: Researchers have found that restoring the normal, helpful bacteria of the gut and intestines may treat patients suffering from recurrent Clostridium difficile infections.
According to scientists at the Institute for Genome Sciences at the University of Maryland School of Medicine and physicians at Sinai Hospital, Baltimore, transplanting fecal matter of healthy donors into patients with recurrent C. difficile infection (RCDI) appears to restore normal bacterial composition and resolve infection.
Patients with RCDI exhibit less diversity of beneficial gut bacteria, which may contribute to disease. Fecal microbiota transplantation (FMT) has recently gained attention as a viable treatment option for patients with RCDI because it aims to restore a normal, functional intestinal bacterial mix in the patient.
The investigators examined a large population of FMT patients and donors, which were sampled at multiple time points up to one year after the treatment at Sinai Hospital of Baltimore.
"Better insight into the microbiota events associated with the disease and FMT-induced recovery could lead to better treatments with a controlled, manufactured microbiota instead of fecal material, which might also prove to be relevant as a treatment option for other microbiota-associated diseases in the future," W. Florian Fricke, one of the lead authors of the paper, said.
The study was published in the journal PLOS ONE.
